Personalized dosing for linezolid in pneumonia or skin infections
Treatments studied
Part of Infections clinical trials.
This trial tests whether a personalized dosing approach for linezolid (an antibiotic) works better than the standard dose. It is for adults with pneumonia or skin/soft tissue infections who have just started or are about to start linezolid.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have pneumonia, or a skin or soft tissue infection
- You have not already received more than 2 doses of linezolid (600 mg each)
- You are not pregnant or breastfeeding
- You are not taking other antibiotics for Gram-positive bacteria at the same time
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adjusting the dose of linezolid based on regular blood tests can help people with multidrug-resistant tuberculosis (MDR-TB) tolerate the medication better while on the BPaL or BPaL-M regimen. It aims to reduce side effects and improve treatment success.
This study tests how best to adjust the dose of an antibiotic called linezolid for people on dialysis. It aims to safely treat infections by using regular blood tests to guide dosing.
This trial tests whether adding linezolid, an antibiotic that stops bacteria from making proteins, to usual care works better for treating Staphylococcus aureus bloodstream infections. You may be eligible if you have this infection and are hospitalized.
This study checks if measuring the amount of linezolid medicine in your blood helps treat rifampin-resistant tuberculosis more safely and effectively. It is for people who have already started a treatment plan that includes linezolid.
This trial tests how quickly two antibiotics (tedizolid vs linezolid) can kill tuberculosis germs in the lungs after a first TB infection is suspected. It may help doctors learn which option works faster and safely in the early treatment phase.
This trial tests a new device that measures antibiotic levels in blood quickly at the bedside, so doctors can adjust your dose to make sure it's effective. It may help ICU patients on beta-lactam antibiotics get the right amount.
Hear when a new Gram-Positive Bacterial Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.